Daily Stock List
Arsenal Energy, Inc. (AEI.TO)
AllPennyStocks reported previously on Arsenal Energy, Inc. (AEI.TO), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Listed on the Toronto Stock Exchange, Arsenal Energy, Inc. is an oil and gas exploration, development and production enterprise. The Company has producing properties in Canada and the United States. Arsenal's production mix is 76 percent crude oil and natural gas liquids and provides the Company with a high operating netback. Arsenal Energy is based in Calgary, Alberta.
The Company concentrates their activities in the United States in North Dakota, as well as in Canada in Alberta and British Columbia. Arsenal Energy produces light oil in North Dakota at Stanley and Lindahl and in Alberta at Evi, and medium oil in Alberta at Provost, Chauvin and Princess. They produce Natural gas at Desan in British Columbia and in Alberta at Chauvin, Princess and Provost.
Yesterday, Arsenal Energy announced a $49 million capital exploration and development budget for 2013. Of this total amount, 68 percent or $33 million is expected to be spent on the drilling and completion of 20 gross (14.63 net) horizontal wells. Successful execution of the budget is expected to increase daily production to approximately 4,500 boe/d by year-end 2013.
In North Dakota, the Company's intention is to drill 7 gross (1.63 net) horizontal wells in the Bakken formation. Six (1.5 net) of the wells are planned to be development wells at Stanley and Lindahl. One well (.13 net) is planned to be Arsenal's first test well at the emerging Rennie Lake/Black Slough property where they've acquired more than 4,700 acres of undeveloped Bakken land.
In Alberta, Arsenal's intention is to drill 13 gross (13 net) horizontal wells. In Q3 2012 the Company drilled two horizontal wells in the Glauconite at Princess. The wells are presently producing at a combined rate of 350 boe/d. Arsenal intends to drill four new wells, the first to spud in December 2012 and 3 additional wells in Q1 2013 in this prospect area. The Company has a 100 percent Working Interest (WI) in all of the wells.
Arsenal has budgeted four 100 percent WI horizontal wells into the Leduc formation at Chauvin. The first well is scheduled for after spring breakup. Additionally, the Company has budgeted one 100 percent WI horizontal well targeting the Cardium/Wilrich formation in the Alberta deep basin.
Arsenal Energy, Inc. (AEI.TO), closed Friday's trading session at $0.57, even for the day, on 102,111 volume. The stock's 52-week low/high is $0.40/$0.86.
Nutrastar International, Inc. (NUIN)
FeedBlitz and SmallCapVoice reported earlier on Nutrastar International, Inc. (NUIN), and we highlight the Company, here at the QualityStocks Daily Newsletter.
Trading on the OTCBB, Nutrastar International, Inc. is a leading producer and supplier of premium branded consumer products. These include commercially cultivated Cordyceps Militaris, functional health beverages, and specialty and organic foods. The Company has their headquarters in Harbin, China. Nutrastar International products sell throughout China through a sales and distribution network that covers more than 10 provinces.
The Company is a leading producer and supplier of premium Cordyceps Militaris-based consumer products. These include small packages of Cordyceps, premium beverages containing Cordyceps, and organic and specialty food products. Cordyceps Militaris is one of the most highly regarded herbal nutrients in Traditional Chinese Medicine (TCM). Cordyceps is a premium TCM consumer product derived from a fungus usually found in high altitude mountainous regions.
Nutrastar International has developed and patented a cultivation process for Cordyceps. This makes it the only company that can produce the natural herb on a mass commercial scale. The Company is the largest producer of this ingredient.
The Company's corporate mission is to focus on bringing innovative consumer products containing their patent-protected Cordyceps product to the market and to provide their customers continuously with the most highly effective synthetic version of Cordyceps available worldwide. Their long-term goal is to become the leading producer and supplier of premium Cordyceps consumer products in the marketplace.
Nutrastar International is the largest producer of this ingredient. They currently produce 72 tons each year, where the estimated worldwide capacity is approximately 250 tons. The Company has their aforementioned Cordyceps distribution network that covers 10 provinces and they introduced, in November of 2010, a beverage distribution network that presently covers two provinces. In addition, Nutrastar is one of the largest wholesale distributors of organic and specialty foods in the Heilongjiang Province of China.
Yesterday, Nutrastar International announced that they appointed Mr. Richard Fearon as a new member of the Company's Board of Directors. Mr. Fearon replaces Mr. Joshua Kurtzig, who resigned from the Board on November 26, 2012. The Board remains comprised of seven members, four of whom are independent, including Mr. Fearon.
Nutrastar International, Inc. (NUIN), closed Friday's trading session at $1.25, up 8.70%, on 27,300 volume with 6 trades. The average volume for the last 60 days is 7,303 and the stock's 52-week low/high is $0.90/$2.45.
Encision, Inc. (ECIA)
SmallCapVoice reported previously on Encision, Inc. (ECIA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Headquartered in Boulder, Colorado, Encision, Inc. designs, develops, manufactures and markets innovative, best of class surgical devices. These devices allow surgeons to optimize technique and patient safety during a wide spectrum of surgical procedures. In February 1991, the Company was established as a Colorado corporation under the name, Electroscope, Inc. In August 2000, they changed their corporate name to Encision, Inc. Encision's shares trade on the OTC Markets: OTCQB.
Encision has developed and launched an innovative surgical technology, called active electrode monitoring (AEM), which has coincided with the expanding public interest in preventing medical errors. AEM® is emerging as a standard of care in minimally invasive surgery across the nation with over 400 hospital customers converting to AEM technology and the number is growing each year.
AEM instruments provide surgeons with the desired tissue effects. They are the only instruments that incorporate a "shielded and monitored" design to prevent the risk of stray energy burn injury from insulation failure and capacitive coupling.
The AEM product line includes all of the standard shapes, sizes and functionality as conventional instruments, but with patented "shielding and monitoring" technology integrated into the design. The Company believes that their active electrode monitoring technology is changing the marketplace for electrosurgical devices and laparoscopic instruments through providing a solution to patient risk in laparoscopic electrosurgery.
The Company's AEM® laparoscopic instruments are available in Fixed-tip Electrodes – Spatulas, J-hooks, L-diamonds; Articulating Instruments – Graspers & Dissectors; Scissors – Reusable & Disposable, as well as Suction-Irrigation Electrodes (SIE) – for Bard-Davol, Applied, Allegiance, Stryker, and Cabot Trumpet Valves.
Last month, Encision released the high performance e•Edge® Scissors to market. This month, the Company launched e•Access® Handle in response to industry trends for cleaning and sterilization of reusable instruments. In addition, this month, Encision received 510k approval for the next generation AEM disposable suction irrigation electrode product line.
Encision, Inc. (ECIA), closed Friday's trading session at $1.00, up 3.10%, on 8,300 volume with 10 trades. The average volume for the last 60 days is 4,137 and the stock's 52-week low/high is $0.725/$1.85.
Affirmative Insurance Holdings, Inc. (AFFM)
SmarTrend Newsletters reported yesterday on Affirmative Insurance Holdings, Inc. (AFFM), StreetInsider did earlier, and we highlight the Company today, here at the QualityStocks Daily Newsletter.
Trading on the OTC Markets: OTCQB, Affirmative Insurance Holdings, Inc. produces and provides non-standard automobile policies and complementary products and services to individual consumers in highly targeted geographic markets. Founded in 1998, the Company is an integrated insurance holding company. Affirmative Insurance is based in Addison, Texas. As of September 30, 2012, their subsidiaries included insurance companies licensed to write insurance policies in 39 states, underwriting agencies, retail agencies with 199 owned stores and a relationship with two unaffiliated underwriting agencies.
Non-standard personal automobile insurance policies provide coverage to drivers who find it difficult to obtain insurance from standard automobile insurance companies because of their lack of prior insurance, age, driving record, limited financial resources or other factors. Non-standard personal automobile insurance policies normally require higher premiums than standard automobile insurance policies for comparable coverage.
Currently, Affirmative Insurance Holdings is active in offering insurance directly to individual consumers via retail stores in 9 states (Louisiana, Texas, Illinois, Alabama, Missouri, Indiana, South Carolina, Kansas and Wisconsin). The Company distributes their own insurance policies through their owned retail stores and approximately 5,100 independent agents or brokers in 8 states (Louisiana, Texas, Illinois, Alabama, California, Missouri, Indiana and South Carolina). In March of 2011, they discontinued writing new business in the state of Michigan, and in June of 2011, they discontinued writing renewals.
Affirmative Insurance Holdings' insurance companies are Affirmative Insurance Company, Insura Property and Casualty Insurance Company, Affirmative Insurance Company of Michigan, USAgencies Casualty Insurance Company, and USAgencies Direct Insurance Company. They offer a wide array of coverage, payment, and term options. They offer liability-only policies and full coverage policies that include first party coverage for the insured's vehicle.
Affirmative Insurance Holdings operates retail agencies. The Company operates their retail stores under four brand names. These are A-Affordable, Driver's Choice, InsureOne, as well as USAgencies. Affirmative Insurance Holdings also distributes their products through independent agencies, unaffiliated underwriting agencies, and through premium finance companies.
Affirmative Insurance Holdings, Inc. (AFFM), closed Friday's trading session at $0.13, up 8.33%, on 6,900 volume with 3 trades. The average volume for the last 60 days is 7,191 and the stock's 52-week low/high is $0.10/$0.60.
Healthient, Inc. (SNAX)
AllPennyStocks, PennyStockVille, CoolPennyStocks, StockEgg, PennyInvest, BullRally, and StockRich reported previously on Healthient, Inc. (SNAX), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
Trading on the OTC Markets: OTCQB, Healthient, Inc. is a network marketing company that sells healthy snacks and beverage mixes. The Company's corporate mission is to assist people in achieving personal success through providing a financially rewarding business opportunity to brand partners and quality products to brand partners and customers who desire a healthy lifestyle. Healthient has their headquarters in Jupiter, Florida.
Healthient is a direct sales enterprise. They focus on building and maintaining their brand partner network through offering financially rewarding and flexible career opportunities through sales of "better for you" snacks to health conscious consumers. The Company believes the income opportunity provided by their network marketing program appeals to a broad cross-section of people globally, particularly those looking to supplement their family incomes, start a home business or pursue entrepreneurial, full and part-time, employment opportunities.
Healthient motivates their brand partners by way of their performance-based compensation plan, individual recognition, reward programs and promotions, and participation in local and national company-sponsored sales events. The Company's commitment is to providing professionally designed educational training materials that their brand partners can use to enhance recruitment and maximize their sales.
Currently, Healthient operates within the U.S. Their strategic plan includes a goal of opening four new markets during 2013. The Company markets and sells 21 products through their brand partners.
Their product categories are Weight Management & Energy, Sports & Fitness; representative products include Smart Shake (Chocolate, Vanilla), CrispyFruit (Pineapple, Fuji Apple, and Banana), LoliBars (Raspberry, Blueberry, Fig, and Apricot/Peach), RealFruit (Organic Pineapple, Organic Mango, Fuji Apple, and Apricot), Lite Natural Microwave Mini Popcorn, Multigrain Pretzel Nuggets, LoliCrunch (Cranberry, Almond, Cashew, and Tropical Fruit & Nut), Low-Sodium Mini-Twist Pretzels, and Zing! Healthy Energy Drink Mix.
The manufacture of Healthient's products is by third party manufacturing companies. Products undergo distribution in the United States market from the Company's third party warehouse and distribution center in Salt Lake City, Utah.
Healthient, Inc. (SNAX), closed Friday's trading session at $0.80, down 3.61%, on 15,500 volume with 9 trades. The average volume for the last 60 days is 7,319 and the stock's 52-week low/high is $0.12/$11.40.
LifeTech Industries, Inc. (LTCH)
Orbit Stocks, SmallCap Fortunes, Beacon Equity Research, Stock Preacher, Investor Soup, Penny Stocks Finder, MicroStockProfit, Stock Roach, The Trading Report, Wyatt Investment Research, The Stock Enthusiast, and PenniesPicks reported yesterday on LifeTech Industries, Inc. (LTCH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
LifeTech Industries, Inc. engages in the business of air to water generator distribution and technology licensing. The Company's business plan is to market and distribute AirWell air to water generation systems and license the technology and corresponding distribution rights to third parties globally. LifeTech Industries lists on the OTC Bulletin Board. The Company has their headquarters in Palo Alto, California.
LifeTech Industries entered into a Joint Venture Agreement, a Distribution Agreement, and a Technology License Agreement with LifeTech Japan Corp., a Japanese corporation. LifeTech acquired the worldwide exclusive right (excluding Japan) to make, use, sell or otherwise distribute LifeTech Japan's atmospheric water generator (AWG) products and technologies.
Additionally, LifeTech Japan has granted the Company an exclusive and perpetual license to any and all of their patents, trademarks and all other intellectual property related to LifeTech Japan's AWG products, and the worldwide exclusive right (excluding Japan) to assign, sublicense or otherwise transfer such rights in LifeTech Japan's technology to third parties, worldwide. All product design, production, and research and development is performed and managed by the Company's strategic partner, LifeTech Japan.
Earlier this week, LifeTech announced that they launched the advanced atmospheric water generator: AirWell Water Systems. Their AirWell System is a highly advanced atmospheric water generator (AWG). It produces healthy drinking water through promoting and filtering the condensation of moisture from air. The AirWell method uses an advanced triple-step gathering system and a 12-step purification process to produce water that is free of chemicals, pollutants, contaminants and hormones.
Yesterday, LifeTech Industries announced the formation and initiation of their International Advisory Board with the appointment of Dr. Hanya Toshio as Chief Technology Advisor. The Advisory Board will provide expert advice to the LifeTech Board of Directors and senior management in specific areas. These areas include specialized expertise in atmospheric water generation technologies; new business opportunities; international law and forms of agreement; international business cultures and negotiations; sustainable business development, and international finance.
LifeTech Industries, Inc. (LTCH), closed Friday's trading session at $1.09, up 2.83%, on 411,352 volume with 213 trades. The average volume for the last 60 days is 18,535 and the stock's 52-week low/high is $0.75/$1.00.
Mint Technology Corp. (MIT.V)
Today we are highlighting Mint Technology Corp. (MIT.V), here at the QualityStocks Daily Newsletter.
Mint Technology Corp. provides vertically integrated prepaid card and payroll services. The Company has 105 employees in 8 offices in the UAE (United Arab Emirates) (3), Qatar, Jordan, Egypt, the United States and Canada. Mint is targeting ultra-niche sectors with high barrier to entry and strong market potential. Mint Technology lists on the TSX Venture Exchange. Established in 2004, the Company has their corporate headquarters in Toronto, Ontario.
Mint Technology is the world's first vertically integrated prepaid card and payroll services provider with their own ATM network, payment-processing platform and proprietary branded card product. This includes microcredit, mobile top up and money remittance services delivered seamlessly to workers throughout the Middle East and North Africa region.
The Company designs, packages, delivers and manages specialized MasterCard® and Visa® branded payment programs for worldwide acceptance and utility for credit card issuers, retailers, and member associations with large consumer bases. Their prepaid payment programs allow card issuers to better service their customers. The Company's key focus is to augment corporate, bank and retailer card programs with prepaid solutions that expand consumer bases and deliver new revenue opportunities.
Mint Technology operates through four subsidiaries, Mint Middle East, a payroll card services provider, Mint Capital (for the Mint Money group of products), a financial products company, Mint Global Processing, a fully integrated third party processing platform and soon to launch, Mint Merchant Services, a POS and ATM network solutions business.
Mint Technology's vision is to achieve recognition as the leading innovative payroll and payment services provider in the MENA (Middle East and North Africa) region by 2014. The Company's strategy is to evolve into a payroll and payment services provider by way of a Holding Company around a group of highly specialized subsidiaries that reflect value chain synergy in different niche segments.
The focus areas of the subsidiaries' are rising from opportunities being presented to Mint Technology by businesses and governments in the MENA region responding to social and economic change in the way wages, payments and purchases are transacted in Emerging Economies. Mint Technology's products and services are providing unbanked consumers with a corridor to financial inclusion.
Mint Technology garners revenue from each program they manage from fixed and variable sources. These include activation fees, recurring monthly fees, load fees, ATM fees, as well as money remittance commissions and interchange fees.
Mint Technology Corp. (MIT.V), closed Friday's trading session at $0.085, up 6.25%, on 984,400 volume. The stock's 52-week low/high is $0.05/$0.23.
AeroGrow International, Inc. (AERO)
Investor News Source reported this week on AeroGrow International, Inc. (AERO), Stock Twiter did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
AeroGrow International, Inc. is the creator, manufacturer and marketer of the AeroGarden line of dirt-free indoor gardens, seed kits, and accessory items for consumer markets globally. AeroGardens allow anyone to grow farmer's market fresh herbs, salad greens, tomatoes, chili peppers, flowers and more, indoors, throughout the year. AeroGrow International lists on the OTC Markets: OTCQB. Founded in 2002, the Company has their corporate headquarters in Boulder, Colorado.
AeroGrow International provides indoor gardens and seed kits that allow consumers to grow vegetables; fresh herbs, including cilantro, chives, basil, dill, oregano, and mint; and flowers, including petunias, snapdragons, pink geraniums, and phlox. The Company offers their products through diverse channels. These include in-house direct mail catalogue, e-mail marketing, and Internet marketing. In addition, AeroGrow sells their products to retailers and international third-party distributors.
The AeroGarden grows plants without dirt using a unique method of hydroponics called Aeroponics. The plant roots are suspended partially in air and partially in an oxygen infused nutrient solution. The roots are bathed with ideal levels of nutrients, water and oxygen. The energy efficient, full spectrum lighting system grows plants anywhere in the home and at anytime of the year.
The Company recently launched a new flagship product, the AeroGarden ULTRA. It represents the first new garden product introduction from AeroGrow in over four years. The Company believes the ULTRA is their biggest, smartest, and highest-producing garden to date. It features more than 100 improvements over the existing garden product line.
Last week, AeroGrow International announced that they opened retail-merchandising kiosks at high-end malls in Arizona and Colorado. They opened three retail kiosks at malls in Colorado and Arizona, including the Arrowhead Towne Center and Chandler Fashion Center in suburban Phoenix, Arizona, and the Flatiron Crossing Mall in Broomfield, Colorado.
Each location will stock AeroGardens, seed kits, and accessories for "cash-and-carry" customers and allow consumers to place orders for direct shipment. Each location will remain open throughout November and December. The Company has substantially increased the breadth and scope of their holiday season marketing plans. AeroGrow has cemented expanded distribution arrangements with Amazon.com and Canadian Tire Corp., as well as several other retailers.
AeroGrow International, Inc. (AERO), closed Friday's trading session at $1.09, even for the day. The average volume for the last 60 days is 74 and the stock's 52-week low/high is $0.25/$5.80.
VistaGen Therapeutics, Inc. (VSTA)
The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.69, up 25.45%, on 2,500 volume with 1 trade. The stock’s average daily volume over the past 60 days is 1,208, and its 52-week low/high is $0.06/$3.15.
VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.
VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.
By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.
Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.
VistaGen's lead drug candidate, AV-101, is in Phase Ib development in the U.S. for treatment of neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system.
Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data. To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.
VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer
VistaGen Therapeutics, Inc. Company Blog
VistaGen Therapeutics, Inc. News:
VistaGen Therapeutics Enhances Predictive Liver Toxicology and Drug Metabolism Bioassay System -- LiverSafe 3D™
VistaGen Therapeutics and Duke University Announce Heart Tissue Engineering Progress at American Heart Association 2012 Scientific Sessions
VistaGen Therapeutics Completes $3.25 Million Financing and $3.0 Million Debt Restructuring
Cardium Therapeutics, Inc. (CXM)
The QualityStocks Daily Newsletter would like to spotlight Cardium Therapeutics, Inc. (CXM). Today, Cardium Therapeutics, Inc. closed trading at $0.216, up 2.86%, on 449,572 volume with 88 trades. The stock’s average daily volume over the past 60 days is 199,382, and its 52-week low/high is $0.17/$0.42.
Cardium Therapeutics, Inc. (CXM) is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.
The company's lead commercial product Excellagen® topical gel for wound care management recently received FDA clearance for marketing and sale in the United States. In addition to plans to advance the product's commercialization in the U.S. and internationally via strategic partnerships, the company plans to develop new product extensions for additional wound healing applications and is working towards securing approval for marketing and sale in South Korea and through the CE Mark application process in the European Union.
Generx®, Cardium's lead clinical development product candidate, is a DNA-based angiogenic biologic designed to treat patients with myocardial ischemia due to coronary artery disease. Cardium recently initiated its Generx Phase 3 / registration study in Russia. Consistent with its capital-efficient business model, Cardium is also actively evaluating new technologies and business opportunities. The company utilizes its team's skills in late-stage product development to bridge the critical gap between promising new technologies and product opportunities that are ready for commercialization.
Cardium is dedicated to building on its core products and product candidates to continually create new opportunities for greater success. Leveraging the advantages of its capital-efficient, asset-based business strategy, the company provides a diversified and more balanced portfolio of risk/return opportunities with the chief objective of providing long-term shareholder value. Disclaimer
Cardium Therapeutics, Inc. Company Blog
Cardium Therapeutics, Inc. News:
Cardium Announces Patent Award For Rights To Gene Therapy for Coronary Heart Disease, Resolves Long-standing IP Competition
Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
TNI BioTech, Inc. (TNIB)
The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $8.87, up 9.78%, on 19,762 volume with 64 trades. The stock’s average daily volume over the past 60 days is 47,166, and its 52-week low/high is $0.72/$10.01.
TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.
The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.
Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.
The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer
TNI BioTech, Inc. Company Blog
TNI BioTech, Inc. News:
TNI BioTech, Inc. Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC
TNI BioTech Inc., and Hubei Qianjiang Pharmaceuticals Co., Ltd., Announce Venture Partnership for the Development of New Drug for Cancer Therapies
Dr. Henry "Skip" Lenz, Pharm.D, Joins TNI BioTech, Inc., as Quality Control Officer
Loans4Less.com, Inc. (LFLS)
The QualityStocks Daily Newsletter would like to spotlight Loans4Less.com, Inc. (LFLS). Today, Loans4Less.com, Inc. closed trading at $0.08, even for the day. The stock’s average daily volume over the past 60 days is 11,507, and its 52-week low/high is $0.01/$0.51.
Loans4Less.com, Inc. (LFLS) is an online mortgage broker which matches qualified individuals seeking mortgage loans with suitable lenders who offer the company a competitive wholesale lending program. Maintaining an A+ TrustLink rating with the Better Business Bureau, the company provides competitive rates, terms, costs, daily updates, extensive market information, and trusted first-class service to the public.
Leveraging its portfolio of 62 different web domains, Loans4Less.com is focused on developing a national consumer platform for conforming residential mortgage programs and implementation of other consumer loan programs via operating providers. The company's expansion strategy includes rapidly growing revenues through strategic and cost-effective advertising, licensing, and/or third party agreements that build national recognition of the Loans4Less® brand.
The management team has accumulated many years of experience in the real estate and financial services sectors. This combination of expertise provides the knowledge and foresight necessary to get the best results for the company and their thousands of loyal clients. The team skillfully navigated through the credit crisis that destroyed much of their competition, putting the company in a stronger position to increase market share.
Loans4Less.com is not exposed to the risks and/or problems that are associated with sub-prime lending. Having never defaulting on an obligation or been involved in any litigation, the company is poised for rapid growth in today's low interest rate environment with its industry leading reputation and well established relationships with respected lenders. Disclaimer
Loans4Less.com, Inc. Company Blog
Loans4Less.com, Inc. News:
Loans4Less.com, Inc. Reports Financial Results for the Third Quarter of 2012
Loans4Less.com Provides Preliminary Financial Results for the Third Quarter of 2012
Loans4Less.com, Inc. New Audio Interview With Chairman and CEO Steven M. Hershman
What a difference a year can make. Toward the end of 2011, the real estate market, and all of the industries that depended upon it, were struggling as perhaps never before in history, and it seemed like the housing slump would continue forever. Housing prices had dropped again in 2011, though not by much, and nothing compared to the double digit losses experienced earlier in the recession.
By some measures, housing prices finally hit a low in February of 2012, and then began to show some life, initiating quarterly rises that continue today. It was the end of a 5-year slide that began back in early 2007. Most recently, the Federal Housing Finance Agency’s seasonally adjusted purchase-only house price index rose by 1.1 percent from the 2nd quarter to the 3rd quarter of 2012. Over the latest four quarters, the index is up 3.3 percent.
The earlier flood in housing inventory is now just a memory, with supply beginning to tread historic lows, down most recently by 17% year-over-year in October 2012. Delinquency rates have also dropped year-over-year and existing home sales are rising. Housing production is also up, though fed more by multi-unit properties, with builder confidence hitting a post crisis high.
This is all exceptional news for real estate based companies such as growing online mortgage loan broker Loans4Less.com. Although the real estate industry is a lot thinner than it used to be, those companies that are around now face a wealth of pent up demand, moderated only by the stricter mortgage policies now in place. And these policies are not as much of a challenge to Loans4Less, which focuses on “A” paper loans. Moreover, the fire is being further stoked by historically low mortgage interest rates.
For more information, visit www.Loans4Less.com
Flexpoint Sensor Systems recently announced that a series of professional promotional videos is now available on the company’s YouTube page. The videos promote the company’s Bend Sensor® technology’s features, advantages, and market potential. Interested parties can access the videos at http://www.youtube.com/user/FlexpointSensor. Flexpoint anticipates that the videos will prove useful as the company expands and gains momentum.
As of Thursday, the company’s YouTube account boasts seven new videos that show the basic manufacturing process and feature demonstrations of how the technology is used in various applications. The videos also highlight a broad range of sensor variations in order to give viewers a sense of the versatility of the technology.
The videos are part of the company’s effort to overhaul its website and represent the latest efforts in Flexpoint’s ongoing marketing push. The YouTube account also contains links to videos uploaded by different users of Bend Sensor® technology. Most of these other videos were shot on low-resolution cameras purely for demonstration purposes and are not considered part of Flexpoint’s formal marketing campaign.
Flexpoint CEO, Clark Mower remarked, “The Bend Sensor® can be challenging to fully describe and its unique features and advantages often only become apparent when we are able to demonstrate the technology in person. With these videos, we aimed to recreate the experience of sitting down with us here at our offices for a full hands-on demonstration. We think these videos do a nice job of providing the basics of what the technology can do and clarify how it is being utilized in various products. Whenever individuals get a vivid sense of what the Bend Sensor® is capable of, they invariably begin to generate new ideas for how it can be used. These videos should help get those creative wheels turning and we are excited to see the responses we get as more and more people see them.”
For more information, visit www.Flexpoint.com
International provider of end-to-end e-commerce solutions PFSweb has announced record consumer traffic and order volumes for the beginning of the 2012 holiday shopping season for its North American End2End consumer packaged goods (CPG), luxury, cosmetic, and apparel clients’ e-commerce direct-to-consumer (E2E DTC) brand sites.
During the course of the Thanksgiving period (Nov. 22 to Nov. 26, including Black Friday and Cyber Monday), PFSweb’s CPG, luxury, cosmetic, and apparel E2E DTC clients’ brand sites in North America received around 364,000 customer orders, with an average order value of more than $102. The company’s client Web sites additionally experienced robust customer traffic, logging approximately 8 million total sessions, which included around 3.7 million new visitors.
On the whole, PFSweb’s North American CPG, luxury, cosmetic, and apparel E2E DTC clients’ brand sites also reported strong same-store-order volumes as compared with the similar period for 2011. This included a 69 percent increase in total customer orders and a 45 percent increase in new visitors. The same-store sales data encompasses data from the CPG, luxury, cosmetic, and apparel E2E DTC clients’ brand e-commerce sites that were operating during the 2011 and 2012 holiday shopping seasons and were supported by PFSweb during both time periods.
As PFSweb anticipated in its operational plans and financial forecasts, the 2012 holiday online retail season in the United States has shown significant improvement over 2011. Infrastructure and technology investments made by PFSweb this year have produced measurable operation benefits for the company and its clients as PFSweb scales its solution to help clients capitalize on the season’s sales opportunities.
PFSweb is engaged in enabling the e-commerce initiatives of iconic brands. The company’s End2End e-commerce solution features interactive marketing services, strong e-commerce technology, global fulfillment and logistics, high-touch customer care, financial services, and order management. The company’s e-commerce solutions offer international reach and expertise in both direct-to-consumer and business-to-business initiatives, supporting organizations across various industries. Headquartered in Allen, Texas, PFSweb has additional locations in Tennessee, Mississippi, Canada, Belgium, and the Philippines.
For more information, visit www.PFSweb.com
National Graphite is positioning itself quite well for huge upcoming moves in the underlying supply/consumption dynamics of the graphite industry, with substantial acreage up in the rich Canadian flake in Quebec, as well as their Chedic Graphite Property in Nevada. The company reported some strong assay results today from sampling taken at the main Chedic production pit, showing a 25-40% grade with the potential to bring in over 1M tons of high-quality graphite.
Independent Geologist contracted by NGRC, John Rud, cited the recent geophysical survey data which showed a target well over 1,500 feet deep ranging from 50 to 150 feet wide, not including the new anomaly, as a strong lead-in indicator of the mineral potential here. Carefully targeted drilling under the soon to be permitted program will be ferreting out the true potential of this exciting site, consisting of 20 mineral lode claims just four miles outside Carson City. The continuous enriched structure was originally started back in the 1900′s with very minimal production ever done and now looks to be richer than ever imagined.
The forthcoming drilling will examine several low resistivity anomalies to the east which represent a clear extension capability for the main production area. Rud noted that the localized geology at Chedic, taken in concert with today’s findings and the existing analytical work, makes the entire project “extremely compelling.” The company obviously has a nice, large, second zone opening up here.
The first anomaly to the east (820 feet from the pit) runs alongside an exploration trench that exposed graphite mineralization and is roughly 1,640 feet or more deep, in excess of 160 feet wide (with a second anomaly detected just north indicating the true width of mineralization may be three times higher at around 490 plus feet). A second drill target just under 1k feet further over plunges to a depth of 1.2k feet at over 100-foot widths. National Graphite’s drilling program will fully probe the relevant anomalies, with a keen eye towards determining the overall grade in both.
Demand for graphite is set to jump 10-12% per year in battery manufacturing alone (Natural & Synthetic Graphite: Global industry markets & outlook, 8th edition 2012). You take into account delimiting of exports by top producer China and a massive future in nanotech where the demand for graphene will be through the roof and you have a perfect logistical storm that benefits small, domestic graphite producers like NGRC.
The company also maintains the Black Butte Project (silver-gold) outside Hawthorne, NV, which has some solid secondary target/indicator metals and clear indications that the relatively limited extant workings are the top of a larger epithermal quartz vein system.
For more information on National Graphite, visit www.NationalGraphiteCorp.com
Today's Top 3
Fast Moving Stocks
First Microcap Report
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Consorteum Holdings, Inc. (CSRH) Files Form 10-K Report With the Securities and Exchange Commission
- Cardium Therapeutics, Inc. (CXM) Announces Patent Award For Rights To Cardiovascular Gene Therapy For The Treatment Of Heart Disease
- DoMark International, Inc. (DOMK) Subsidiary and Infrared/Solar Apple Accessory Leader, SolaWerks™, Launches New Website
- The Guitammer Company Inc. (GTMM) Insiders Acquire An Aggregate Of 156,000 GTMM Shares In Open Market Purchases
- GlobalWise Investments, Inc. (GWIV) Reports Third Quarter 2012 Financial Results and Provides Revised Fiscal 2012 Guidance
- International Stem Cell Corp. (ISCO) Announces Significant Progress Towards Clinical Development
- Loans4Less.com, Inc. (LFLS) Reports Financial Results for the Third Quarter of 2012
- TNI BioTech Inc. (TNIB) Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC
- Viaspace, Inc. (VSPC) Board Chairman and CEO Conduct Interview With The Green Baron Report
- VistaGen Therapeutics, Inc. (VSTA) Enhances Predictive Liver Toxicology and Drug Metabolism Bioassay System -- LiverSafe 3D™